Huahai Pharma Gets Registration Certificate for Metaraminol Bitartrate Injection
Zhejiang Huahai Pharmaceutical (SHA:600521) received a drug registration certificate from China's National Medical Products Administration for metaraminol bitartrate injection, according to a Shanghai bourse filing on Friday. The drug is used to treat hypotension. The pharmaceutical company's shares jumped 3% at the close.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.